Janus Henderson Group’s BlossomHill Therapeutics BLSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.9M Buy
+1,336,993
New +$26.6M 0.01% 591

Other funds holding BLSM

Janus Henderson Group's BLSM Position: Q3 2026 in Review

Janus Henderson Group opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 1,336,993 shares worth $24.9M. The stake represents 0.01% of the portfolio and ranks #591 among its holdings.

39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.

  • Janus Henderson Group held 1,336,993 shares of BlossomHill Therapeutics worth $24.9M as of Q3 2026.
  • BlossomHill Therapeutics was a new Janus Henderson Group position in Q3 2026.
  • BlossomHill Therapeutics made up 0.01% of Janus Henderson Group's portfolio in Q3 2026, its #591 holding.
  • 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.

Based on Janus Henderson Group's 13F filing for Q3 2026, filed 16 Nov 2026.